Now that Facebook's new commenting policy is forcing every pharmaceutical to rethink it's Facebook strategy -- ie, take down all disease-specific pages but keep corporate pages -- many drug companies are revising their corporate FB pages.
Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity.
Compare BI to Pfizer FB pages here: http://bit.ly/oFzZfeBI continues "pushing the envelope outside the boundaries" in social media. It recently created a YouTube video that spoofs efforts to pronounce the company's name through "word of mouth" (WOM) marketing. See "BI's Famously Buxom and Unpronounceable YouTube Video."